Vitalibis, Inc.
VCBDQ · OTC
9/30/2020 | 6/30/2020 | 3/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 49.3% | -1.7% | -28.8% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 42.4% | 47% | 56.9% | 60.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $2 |
| SG&A Expenses | $0 | $0 | $0 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $2 |
| Operating Income | -$0 | -$0 | -$0 | -$2 |
| % Margin | -100.2% | -126% | -401.2% | -3,286.1% |
| Other Income/Exp. Net | $0 | -$1 | -$1 | $0 |
| Pre-Tax Income | -$0 | -$1 | -$1 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$1 | -$1 | -$2 |
| % Margin | -7.1% | -1,770.2% | -1,845.1% | -3,056% |
| EPS | -0 | -0.013 | -0.028 | -0.069 |
| % Growth | 99.7% | 55.7% | 58.9% | – |
| EPS Diluted | -0 | -0.013 | -0.028 | -0.069 |
| Weighted Avg Shares Out | 154 | 70 | 33 | 31 |
| Weighted Avg Shares Out Dil | 70 | 70 | 33 | 31 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | -$0 | -$2 |
| % Margin | 264.1% | 116.4% | -234.6% | -2,654.1% |